Please check your internet connection and try again.
## Lorazepam
### Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA).
### Primary Indications
* Management of anxiety disorders
* Insomnia due to anxiety or transient situational stress
* Status epilepticus
* Sedation/anxiolysis prior to procedures
### Adult Dosing
* **Anxiety Disorders:** 1-3 mg orally 2-3 times daily. Maximum dose typically 10 mg/day.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg (IV or IM). A second dose of 4 mg may be administered 5-10 minutes after the first if seizures persist.
* **Preoperative Sedation:** 2-4 mg IM 2 hours before surgery.
* **Intravenous Administration (e.g., procedural sedation):** 0.044 mg/kg (up to 4 mg) per dose, administered slowly (e.g., 2 mg/min). Dosing is highly individualized based on patient response and procedure.
### Pediatric Dosing
Dosing in children is less established and should be individualized based on age, weight, and clinical condition.
* **Status Epilepticus:** 0.1 mg/kg (maximum 4 mg) IM or IV. May be repeated once after 5-10 minutes.
* **Sedation/Anxiolysis (less common, typically for procedures):** Doses are highly variable and should be determined by a clinician experienced in pediatric sedation.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require dose reduction.
* **Renal Impairment:** No specific dose adjustment, but use with caution.
* **Elderly:** Start with lower doses (e.g., 1-2 mg/day) and titrate slowly due to increased sensitivity and risk of side effects.
### Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines
* Acute angle-closure glaucoma
### Adverse Effects
Common: Sedation, dizziness, weakness, unsteadiness, fatigue, disorientation.
Serious: Respiratory depression (especially with IV administration or in combination with other CNS depressants), paradoxical reactions (agitation, excitement), anterograde amnesia, dependence, withdrawal symptoms.
### Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Potentiates CNS depression, increasing risk of sedation, respiratory depression, coma, and death.
* **Theophyllines and Aminophylline:** May antagonize the sedative effects of benzodiazepines.
* **Valproic Acid:** May increase lorazepam plasma concentrations and increase the risk of sedation.
### Monitoring
* Respiratory rate, depth, and oxygen saturation (especially with IV administration).
* Level of consciousness and sedation.
* Signs of withdrawal if discontinuation is considered.
* Effectiveness for the intended indication.
### Clinical Pearls
* Lorazepam has a relatively long half-life compared to some other benzodiazepines, but its intermediate half-life makes it suitable for both acute and longer-term management.
* Intramuscular (IM) absorption is generally reliable.
* Intravenous (IV) lorazepam should be administered slowly to minimize adverse effects like respiratory depression and hypotension.
* Avoid abrupt discontinuation; taper doses gradually to prevent withdrawal symptoms.
* Use in elderly patients requires caution due to increased risk of falls and cognitive impairment.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making clinical decisions.*
